News

News2021-06-14T13:17:18+02:00

Microviable welcomes Pilar Manrique, PhD on board

28 de September de 2022|

Welcome Pilar Manrique, PhD on board. Pilar obtained her undergraduate degree in Biotechnology at Universidad Francisco de Vitoria (2009) and her doctorate at Montana State University (2018). Pilar has worked over ten years studying the [...]

Microviable Therapeutics will be presenting at AIMID 2022 Meeting

16 de September de 2022|

Microviable Therapeutics will be presenting at I Asturias International Meeting on Clinical Microbiology and Infectious Disease (AIMID 2022) on September 22-23. Claudio Hidalgo, CEO at Microviable, will discuss the use of “Microbiome-derived biotherapeutic products for [...]

Microviable Therapeutics welcomes Manuel Arenal on board

6 de July de 2022|

Microviable Therapeutics welcomes Manuel Arenal on board. He has Master´s degree in Business Administration and Management at the University of Oviedo (MBA, 2015). He holds Master in Management at the ESC Clermont-Ferrand (2016) although he [...]

MICROVIABLE THERAPEUTICS

CONTACT US

CONTACT
Go to Top